| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 03/07/2002 | US20020028484 Expression vector for use in the treatment and prevention of viral diseases |
| 03/07/2002 | US20020028438 Prebleaching blood sample |
| 03/07/2002 | US20020028437 Prebleaching blood sample |
| 03/07/2002 | US20020028432 Side effect reduction using quencher; storage stability |
| 03/07/2002 | US20020028212 Recombinant viruses coding for a glutamate decarboxylase (gad) activity |
| 03/07/2002 | US20020028207 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
| 03/07/2002 | US20020028205 May be comprised of a heavily glycosylated mucin part, which mediates binding to selectins, such as PSGL-1; absorber to prevent a hyperacute rejection of a xenotransplant |
| 03/07/2002 | US20020028196 Administration of an effective amount of D-Ribose to a mammal that would benefit enhancement of the immune response. |
| 03/07/2002 | US20020028195 Viruses for the treatment of cellular proliferative disorders |
| 03/07/2002 | US20020028194 DNA encoding a transcription unit comprising a transgene linked to expression control sequences, a an adenovirus E3 region, and a modified E4 region containing E4ORF3, and at least one other portion of an adenovirus E4 region |
| 03/07/2002 | DE10038722A1 Verfahren zur Reduzierung von spezifischen Immunreaktionen A process for the reduction of specific immune responses |
| 03/07/2002 | CA2457162A1 Electroprocessed fibrin-based matrices and tissues |
| 03/07/2002 | CA2424146A1 Use of a composition comprising an extract of pollen for the treatment of hormonally-related disorders |
| 03/07/2002 | CA2424052A1 Packaging of positive-strand rna virus replicon particles |
| 03/07/2002 | CA2424026A1 Use of a composition comprising an extract of pollen for the treatment of dysphoria |
| 03/07/2002 | CA2424011A1 Use of a composition comprising an extract of pollen for the treatment of disease-related weight gain |
| 03/07/2002 | CA2421106A1 Manzamines for treatment of drug resistant infection |
| 03/07/2002 | CA2420906A1 Use of a composition comprising an extract of pollen for the treatment of edema |
| 03/07/2002 | CA2420879A1 Anti-microbial agents |
| 03/07/2002 | CA2420832A1 Methods and reagents for protease inhibition |
| 03/07/2002 | CA2420823A1 Use of a composition comprising an extract of pollen for the treatment of irritability |
| 03/07/2002 | CA2420765A1 Anti-angiogenic peptides |
| 03/07/2002 | CA2420652A1 Vertebrate intestinal protein which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport |
| 03/06/2002 | EP1183384A1 Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders |
| 03/06/2002 | EP1183383A1 Siv-based packaging-deficient vectors |
| 03/06/2002 | EP1183382A2 Method for selecting improved vectors |
| 03/06/2002 | EP1183371A2 Composition designed for implementing an antitumoral or antiviral treatment in a mammal |
| 03/06/2002 | EP1183367A1 Cytotoxic t-cell epitopes of the papillomavirus l1-protein and use thereof in diagnostics and therapy |
| 03/06/2002 | EP1183361A1 Gene therapy of pulmonary disease |
| 03/06/2002 | EP1183348A2 Compositions for the treatment and diagnosis of breast cancer and methods for their use |
| 03/06/2002 | EP1183329A2 Differentiated human embryoid cells and a method for producing them |
| 03/06/2002 | EP1183273A1 C-cam as an angiogenesis inhibitor |
| 03/06/2002 | EP1183269A1 Attenuated microorganisms for the treatment of infection |
| 03/06/2002 | EP1183051A2 Use of recombinant gene delivery vectors for treating or preventing diseases of the eye |
| 03/06/2002 | EP1183049A2 Modification of biological elements |
| 03/06/2002 | EP1183047A2 Pharmaceutical preparation |
| 03/06/2002 | EP1183037A2 Methods and compositions for modulating immune response and for the treatment of inflammatory disease |
| 03/06/2002 | EP1183036A1 Method for preparing dual virally inactivated immune globulin for intravenous administration |
| 03/06/2002 | EP1183035A1 Bone marrow transplantation for treatment of stroke |
| 03/06/2002 | EP1182929A1 Osteonectin based toxic gene therapy for the treatment of calcified tumors and tissues |
| 03/06/2002 | EP1182926A1 Method of cryopreservation of blood vessels by vitrification |
| 03/06/2002 | EP1003534B1 Reovirus for the treatment of neoplasia |
| 03/06/2002 | EP0848757B1 The use of the wap of mmtv regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells |
| 03/06/2002 | EP0845999B1 Method for the production of tablets by pressing and tablets produced by the method |
| 03/06/2002 | EP0694071B1 Adenovirus for the transfer of foreign dna into higher eucaryotic cells |
| 03/06/2002 | CN1338940A Bidifobacterium in the treatment of inflammatory disease |
| 03/06/2002 | CN1338466A Polypeptide with alpha-galactosidase activity and its coding nucleic acid |
| 03/06/2002 | CN1338297A Orally applied medicine 'Gukangwang' for treating arthropathy and its preparing process |
| 03/06/2002 | CN1338296A Orally applied medicine 'Zhuanyangsan' for treating diseases caused by Yang deficiency and its preparing process |
| 03/06/2002 | CN1338292A Liquid medicine for treating burn and scald |
| 03/06/2002 | CN1338290A Ointment for treating burn |
| 03/06/2002 | CN1338286A Chinese medicine for treating chronic laryingitis and vocal fold node and process for preparing its granular medicine |
| 03/06/2002 | CN1338284A 复方鲨鱼软骨素 Complex Shark Cartilage |
| 03/06/2002 | CN1338282A Bone-setting medicine and its preparing process |
| 03/06/2002 | CN1338274A Powdered medicine 'Shaotangsan' for treating burn and scald |
| 03/06/2002 | CN1338261A Bear gall pill |
| 03/06/2002 | CN1080299C Vaccinal efficacy augmentor and efficacy augmenting foods |
| 03/06/2002 | CN1080295C Antioxidant composition and production thereof |
| 03/06/2002 | CN1080130C In vitro conea equivalent model |
| 03/05/2002 | US6353150 Chimeric mammals with human hematopoietic cells |
| 03/05/2002 | US6353089 Stimulating proliferation of cytotoxic lymphocytes cells by exposing a fluid sample with a major histocompatability complex and incubate to allow lysis of the presenting cells |
| 03/05/2002 | US6352856 A poxvirus geneome containing a replication defective retroviral proviral genome; for gene therapy or tumor therapy, therapy for cystic fibrosis, hemophilia |
| 03/05/2002 | US6352723 Homogenate containing alkali soluble active factor which inhibits antigen-stimulated lymphocyte proliferation but intensifies with mitogen-stimulated proliferation |
| 03/05/2002 | US6352707 Comprising gelatin, dextran, nitric oxide inhibitor, and arginine, lysine, histidine, glutamic acid, or aspartic acid |
| 03/05/2002 | US6352698 Free radical scavenger, antiallergen, and antiinflammatory agents |
| 03/05/2002 | US6352694 Immunotherapy; biochemical immobilization; genetic engineering; medical diagnosis |
| 03/05/2002 | US6352685 External preparation for skin |
| 03/05/2002 | US6352555 Methods for implanting cells |
| 03/05/2002 | CA2356543A1 Process and composition for improving the growth of human head hair |
| 02/28/2002 | WO2002016620A2 Modulation of stem cell differentiation |
| 02/28/2002 | WO2002016612A2 Genes and proteins, and their uses |
| 02/28/2002 | WO2002016560A1 Method for producing ready to use, antigen loaded or unloaded, cryoconserved mature dendritic cells |
| 02/28/2002 | WO2002016554A1 Probiotics products containing lactic acid bacterium |
| 02/28/2002 | WO2002016553A2 Regulator gene and system useful for the diagnosis and therapy of osteoporosis |
| 02/28/2002 | WO2002016426A2 Coaster, a human coactivator of steroid receptors |
| 02/28/2002 | WO2002016413A2 Cripto tumour polypeptide |
| 02/28/2002 | WO2002015952A1 Scaffolds for tissue engineered hair |
| 02/28/2002 | WO2002015918A2 Method and compositions for promoting osteogenesis |
| 02/28/2002 | WO2002015915A2 Method for inducing an anti-tumor and anti-cachexia immune response in mammals |
| 02/28/2002 | WO2002015914A1 Vascularised tissue graft |
| 02/28/2002 | WO2002015887A1 Consumable container |
| 02/28/2002 | WO2002015881A2 Use of a porous carrier |
| 02/28/2002 | WO2001085779A3 Protein complexes and assays for screening anti-cancer agents |
| 02/28/2002 | WO2001085762A3 Cancer diagnosis and assays for screening anti-cancer agents |
| 02/28/2002 | WO2001079271A9 Albumin fusion proteins |
| 02/28/2002 | WO2001079258A9 Albumin fusion proteins |
| 02/28/2002 | WO2001072970A3 Methods to prepare and use epidermal stem cells |
| 02/28/2002 | WO2001066150A9 Highly efficient gene transfer into human repopulating stem cel ls by rd114 pseudotyped retroviral vector particles |
| 02/28/2002 | WO2001064847A3 In vitro modification of cardiac valvular xenografts |
| 02/28/2002 | WO2001062895A3 Simultaneous stimulation and concentration of cells |
| 02/28/2002 | WO2001058936A3 Constructs for delivery of therapeutic agents to neuronal cells |
| 02/28/2002 | WO2001043755A3 Regenerative adjuvant (3-way tap) |
| 02/28/2002 | WO2001042474A3 Interferon-like molecules and uses thereof |
| 02/28/2002 | WO2001041776B1 Use of honey in medical dressings |
| 02/28/2002 | WO2001040444A3 Method and compositions for producing cell transplants |
| 02/28/2002 | WO2001027254A3 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy |
| 02/28/2002 | WO2001024804A3 Method for preparing a composition by mother-of-pearl extraction, and use thereof in cosmetics and dermatology |
| 02/28/2002 | WO2001023414B1 Immunologically significant herpes simplex virus antigens |
| 02/28/2002 | WO2001015755A3 Methods and compositions for delivery of pharmaceutical agents |
| 02/28/2002 | US20020026655 Genetically engineered Salmonella for use in the treatment of cancer |